STOCK TITAN

Cannabix Technol - BLOZF STOCK NEWS

Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.

About Cannabix Technologies Inc.

Cannabix Technologies Inc. (OTC: BLOZF) is a pioneering developer of advanced breathalyzer technologies designed to detect marijuana (delta-9 THC) and alcohol use. The company’s innovative solutions cater to critical industries, including law enforcement, workplace safety, and regulatory compliance programs. By focusing on real-time detection of substances, Cannabix addresses the growing public safety and operational challenges associated with impairment from marijuana and alcohol.

Core Technologies and Features

The company’s flagship products, including the Breath Logix Industrial and Workplace Series, are autonomous, wall-mounted breathalyzer devices equipped with cutting-edge features. These include patent-pending pre-calibrated cartridge technology, weather-resistant designs, and real-time reporting capabilities. The devices are designed for diverse applications, such as pre-access testing, random testing, start-of-shift testing, pre-employment screening, and post-incident investigations. Cannabix’s technology also integrates with biometric identification systems and access control devices, enhancing its utility in safety-sensitive environments.

Cannabix is also advancing its Marijuana Breathalyzer (CMB), which focuses on detecting recent use of delta-9 THC, the psychoactive component of marijuana. Unlike traditional methods such as urine or blood tests, which can detect THC long after impairment has subsided, Cannabix’s breathalyzer technology provides a more accurate assessment of current impairment, making it a vital tool for law enforcement and employers.

Market Applications

The company’s breathalyzer solutions are tailored for a wide range of industries, including:

  • Law Enforcement: Tools to detect marijuana and alcohol impairment in real-time, addressing challenges in road safety and DUI enforcement.
  • Workplace Safety: Autonomous devices to ensure compliance with substance use policies, reducing accidents and enhancing productivity.
  • Regulatory Programs: Solutions for initiatives like the U.S. 24/7 Sobriety Program, which aims to reduce re-arrests through daily alcohol testing.
  • Industrial and High-Risk Environments: Pre-access and random testing for sectors such as mining, oil and gas, and transportation.

Competitive Advantages

Cannabix Technologies differentiates itself through its focus on innovation and user-centric design. Key advantages include:

  • Recent-Use Detection: A unique approach to marijuana testing that identifies recent use rather than residual traces, ensuring more accurate assessments of impairment.
  • Autonomous Operation: Devices that operate without the need for dedicated administrators, reducing costs and improving efficiency for organizations.
  • Scalability: Versatile applications across various industries and settings, from small businesses to large-scale regulatory programs.
  • Regulatory Alignment: Active efforts to meet certification requirements in key markets, including the U.S., Canada, Australia, and Europe.

Industry Significance

As marijuana legalization expands globally and workplace safety remains a top priority, the demand for reliable impairment detection tools is growing. Cannabix is well-positioned to capitalize on this trend, offering solutions that bridge the gap between traditional testing methods and the need for real-time, accurate assessments. By addressing critical safety concerns, the company plays a pivotal role in enhancing public safety and operational efficiency.

Conclusion

With its innovative technologies, strategic market focus, and commitment to regulatory compliance, Cannabix Technologies Inc. is at the forefront of the evolving landscape of substance impairment detection. The company’s solutions not only improve safety but also empower organizations to implement cost-effective, efficient testing protocols, making it a key player in this critical industry.

Rhea-AI Summary
Cannabix Technologies Inc. will be presenting its marijuana breathalyzer technology at the International Association for Chemical Testing (IACT) conference. The presentation will cover the science and technology behind cannabis breath testing, aiming to enhance public safety for law enforcement and workplace environments. Dr. Bruce Goldberger, a renowned expert in forensic medicine, will lead the workshop session discussing the pharmacokinetics and pharmacodynamics of cannabinoids in breath, collection devices, laboratory workflows, and analytical considerations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.26%
Tags
conferences
-
Rhea-AI Summary
Cannabix Technologies begins certification of contactless alcohol breathalyzer and rebrands product series to Breath Logix. The company ships its Industrial Series Contactless Alcohol Breathalyzers for certification testing, introducing new features and technology to improve workplace alcohol testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.09%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. announces Dr. Phillip Olla joining the board of directors, bringing expertise in breath technologies and healthcare innovation. The company also reports the cancellation of 1.5 million stock options and the granting of 2.7 million incentive stock options to directors and consultants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
management
Rhea-AI Summary
Cannabix Technologies Inc. successfully analyzed breath samples from a green lab testing day in Maryland at a third-party location for the first time. The data showed quantified delta9-THC from smoking and edibles consumption, marking a critical step in reproducibility of Cannabix hardware and analysis methods. The Company's breath collection unit and laboratory breath sampler are being used to provide a new method for drug detection that complements gold-standard mass spectrometry and significantly simplifies laboratory analysis methods.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) has filed a provisional patent application for its Mass Spectrometer Breath Sampler technology, allowing for the rapid and efficient analysis of low volatility analytes like delta-9 THC in human breath samples. The company's innovative hardware device simplifies laboratory analysis methods and provides consistent results in detecting THC from smoking and edibles up to 4 hours after consumption.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.14%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) announces participation in 'green lab' testing day in Montgomery County, Maryland to showcase its marijuana breathalyzer technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.81%
Tags
conferences
Rhea-AI Summary
Cannabix Technologies Inc. has completed preliminary third-party testing on its Contactless Alcohol Breathalyzer (CAB) wall-mounted device, nearing completion of its first commercial version. The CAB workplace series is being prepared for international alcohol standards testing, with a new product name and branding in the works. The device is designed to address workplace safety concerns related to alcohol and marijuana use, offering a targeted solution for employers and organizations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.49%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies reports successful quantification of delta-9 THC levels in breath using its MSBS technology. Achieved limit of detection and quantification in the low picogram range. Potential wide-ranging benefits for law enforcement, government, and industry. Re-classification of marijuana as a lower-risk substance may increase demand for THC testing technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.88%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.02%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none

FAQ

What is the current stock price of Cannabix Technol (BLOZF)?

The current stock price of Cannabix Technol (BLOZF) is $0.3 as of February 28, 2025.

What is the market cap of Cannabix Technol (BLOZF)?

The market cap of Cannabix Technol (BLOZF) is approximately 37.2M.

What does Cannabix Technologies Inc. specialize in?

Cannabix Technologies specializes in developing marijuana and alcohol breathalyzer devices for law enforcement, workplaces, and regulatory programs.

What is unique about Cannabix’s marijuana breathalyzer technology?

Cannabix’s marijuana breathalyzer focuses on detecting recent use of delta-9 THC, providing a more accurate assessment of current impairment compared to traditional methods.

What industries benefit from Cannabix’s technologies?

Industries such as law enforcement, workplace safety, industrial operations, and regulatory compliance programs benefit from Cannabix’s breathalyzer solutions.

How do Cannabix’s devices improve workplace safety?

Cannabix’s autonomous devices enable pre-access and random testing, reducing accidents and ensuring compliance with substance use policies in safety-sensitive environments.

What are the key features of Cannabix’s breathalyzer devices?

Key features include autonomous operation, pre-calibrated cartridge technology, real-time reporting, and integration with biometric systems for enhanced safety and efficiency.

What challenges does Cannabix address in law enforcement?

Cannabix provides tools to detect marijuana and alcohol impairment in real-time, addressing challenges in DUI enforcement and road safety.

Does Cannabix operate internationally?

Yes, Cannabix is pursuing regulatory certifications to market its devices in the U.S., Canada, Australia, Europe, and other regions.

What is the Breath Logix Industrial Series?

The Breath Logix Industrial Series is a ruggedized, autonomous alcohol breathalyzer device designed for workplace safety and regulatory programs.

How does Cannabix’s technology save organizations money?

By eliminating the need for dedicated administrators and costly calibration equipment, Cannabix’s autonomous devices reduce operational costs and improve efficiency.

What makes Cannabix a key player in the substance detection market?

Cannabix’s focus on innovation, real-time detection, and regulatory compliance positions it as a leader in addressing critical safety and impairment challenges.
Cannabix Technol

OTC:BLOZF

BLOZF Rankings

BLOZF Stock Data

37.19M
105.55M
8.33%
0.01%
Medical Devices
Healthcare
Link
Canada
Burnaby